FrancophonIA/ELRC3.0 huggingface dataset:
English: Before treatment with radiolabelled Zevalin, the patients must first receive an infusion of rituximab (at a dose lower than would be used for treatment) to clear B cells from their circulation, leaving the cancerous B cells in the lymph tissue.
Slovenian: Pred zdravljenjem z radioaktivno označenim zdravilom Zevalin morajo bolniki najprej dobiti infuzijo rituksimaba (v nižjem odmerku od tistega, ki se sicer uporablja za zdravljenje), da celice B očistijo iz obtoka in pustijo rakave celice B v limfnem tkivu.
English: Why has Zevalin been approved?
Slovenian: Zakaj je bilo zdravilo Zevalin odobreno?
English: The main study compared the effectiveness of Zevalin with that of rituximab in 143 patients.
Slovenian: V glavni študiji so pri 143 bolnikih primerjali učinkovitost zdravila Zevalin z učinkovitostjo rituksimaba.
English: Zevalin has also been studied in a total of 306 patients with non Hodgkin's lymphoma who were not responding to other treatments or whose disease had come back after previous treatment.
Slovenian: Zdravilo Zevalin so proučevali tudi pri skupno 306 bolnikih z ne-Hodgkinovim limfomom, ki se niso odzivali na druga zdravljenja ali pri katerih se je bolezen po predhodnem zdravljenju ponovila.
English: When Zevalin is radiolabelled, the radioactive element yttrium 90 (90Y) is attached to ibritumomab.
Slovenian: Ko se zdravilo Zevalin radioaktivno označi, se radioaktivni element itrij90 (90Y) veže na ibritumomab.
English: • patients who have gone into remission (reduction in the number of cancerous cells) after their first
Slovenian: • bolnikih, ki so prešli v remisijo (zmanjšanje števila rakavih celic) po prvem „indukcijskem zdravljenju“ (začetno zdravljenje s kemoterapijo) limfoma.
English: Radiolabelling is a technique where a substance is tagged (labelled) with a radioactive compound.
Slovenian: Radioaktivno označevanje je tehnika, pri kateri se učinkovina označi z radioaktivno snovjo.
English: This enables Zevalin to deliver radiation more specifically to the cancerous B-cells.
Slovenian: To zdravilu Zevalin omogoča, da se radioaktivno sevanje posebej osredotoči na rakave celice B..
English: ‘consolidation therapy' to improve the remission; patients in whom rituximab (another treatment for non Hodgkin's lymphoma) is no longer effective or whose disease has come back after rituximab treatment.
Slovenian: Zdravilo Zevalin se daje kot „konsolidacijska terapija“ za izboljšanje remisije; bolnikih, pri katerih rituksimab (druga oblika zdravila za ne-Hodgkinov limfom) ni več učinkovit ali katerih bolezen se je ponovno pojavila po zdravljenju z rituksimabom.
English: Zevalin is radiolabelled by mixing it with a solution of radioactive yttrium (90Y) chloride.
Slovenian: Zdravilo Zevalin se radioaktivno označi tako, da se zmeša z raztopino radioaktivnega itrijevega (90Y) klorida.
English: The CHMP decided that Zevalin's benefits are greater than its risks as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma and for the treatment of adult patients with rituximab relapsed or refractory CD20-positive follicular B cell non Hodgkin's lymphoma.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Zevalin kot konsolidacijska terapija po indukciji remisije pri predhodno nezdravljenih bolnikih s folikularnim limfomom in za zdravljenje folikularnih celic B CD20+ pri odraslih bolnikih z ne-Hodgkinovim limfomom, ki se je po zdravljenju z rituksimabom ponovil ali je zanj neodziven, večje od z njim povezanih tveganj.
English: In an additional study, 57 patients with follicular lymphoma who had been previously treated and were not responding to rituximab received Zevalin.
Slovenian: V dodatni študiji je zdravilo Zevalin prejelo 57 bolnikov s folikularnim limfomom, ki so bili predhodno zdravljeni in se niso odzivali na rituksimab.
English: What is Zevalin used for?
Slovenian: Za kaj se zdravilo Zevalin uporablja?
English: How has Zevalin been studied?
Slovenian: Kako je bilo zdravilo Zevalin raziskano?
English: What is Zevalin?
Slovenian: Kaj je zdravilo Zevalin?
English: Zevalin is a kit for the preparation of a ‘radiolabelled' infusion (drip into a vein) of the active substance ibritumomab tiuxetan.
Slovenian: Zdravilo Zevalin je komplet za pripravo radioaktivno označene infuzije (kapalne infuzije v veno) zdravilne učinkovine ibritumomab tiuksetan.
English: How does Zevalin work?
Slovenian: Kako zdravilo Zevalin deluje?
English: When the radiolabelled medicine is injected into the patient, the monoclonal antibody carries the radioactivity to the target CD20 antigen on the B cells.
Slovenian: Z injiciranjem radioaktivno označenega zdravila v bolnika monoklonsko protitelo prenese radioaktivnost do ciljnega antigena CD20 v celicah B. Ko se protitelo veže na antigen, lahko začne sevanje lokalno delovati in uničevati limfom celic B.
English: How is Zevalin used?
Slovenian: Kako se zdravilo Zevalin uporablja?
English: • The radiolabelled medicine is used to treat adult patients with follicular B cell non Hodgkin's lymphoma.
Slovenian: • Radioaktivno označeno zdravilo se uporablja za zdravljenje odraslih bolnikov z ne-Hodgkinovim limfomom folikularnih celic B. To je rak limfnega tkiva (dela imunskega sistema), ki prizadene vrsto belih krvničk, imenovano limfociti B ali celice B. Zdravilo Zevalin se uporablja pri naslednjih skupinah bolnikov:
English: It is used to treat adults with the following conditions:
Slovenian: Uporablja se za zdravljenje odraslih z naslednjimi boleznimi:
English: This medicine is the same as Lyrica, which is already authorised in the European Union (EU).
Slovenian: Zdravilo je enako zdravilu Lyrica, ki je že odobreno v Evropski uniji (EU).
English: The medicine can only be obtained with a prescription and is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg).
Slovenian: Na voljo je v obliki kapsul (25, 50, 75, 100, 150, 200, 225 in 300 mg).
English: Neurotransmitters are chemicals that allow nerve cells to communicate with each other.
Slovenian: Živčni prenašalci so kemične snovi, ki omogočajo medsebojno komunikacijo živčnih celic.
English: Patients who have kidney problems need to take lower doses.
Slovenian: Bolniki, ki imajo težave z ledvicami, morajo jemati manjše odmerke.
English: The capsules should be swallowed whole with water.
Slovenian: Kapsule morajo bolniki pogoltniti cele, skupaj z vodo.
English: The exact way that pregabalin works is not fully understood, but it is thought to affect the way that calcium enters nerve cells.
Slovenian: Točno delovanje pregabalina ni popolnoma znano, vendar naj bi vplival na vstopanje kalcija v živčne celice.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pregabalin Pfizer on 10 April 2014.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Pregabalin Pfizer, veljavno po vsej Evropski uniji, izdala 10. aprila 2014.
English: This compared with about 10% of the patients taking placebo.
Slovenian: Ta delež je pri bolnikih, ki so jemali placebo, znašal okrog 10 %.
English: • epilepsy, where it is used as an ‘add-on' to existing treatment in patients who have partial seizures (epileptic fits starting in one specific part of the brain) that cannot be controlled with their current treatment;
Slovenian: • epilepsijo, pri čemer se uporablja kot dodatek k obstoječemu zdravljenju pri bolnikih s parcialnimi napadi (epileptični napadi, ki izvirajo iz določenega dela možganov), ki jih ni mogoče nadzorovati s trenutnim zdravljenjem;
English: The full EPAR and risk management plan summary for Pregabalin Pfizer can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) in povzetek načrta obvladovanja tveganj za zdravilo Pregabalin Pfizer sta na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The active substance in Pregabalin Pfizer, pregabalin, is similar in structure to the body's own ‘neurotransmitter' gamma-amino butyric acid (GABA), but has very different biological effects.
Slovenian: Zdravilna učinkovina v zdravilu Pregabalin Pfizer, pregabalin, ima podobno zgradbo kot telesu lastni „živčni prenašalec“ gama-aminomaslena kislina (GABA), vendar ima bistveno drugačne biološke učinke.
English: This is a summary of the European public assessment report (EPAR) for Pregabalin Pfizer.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Pregabalin Pfizer.
English: What measures are being taken to ensure the safe and effective use of Pregabalin Pfizer?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Pregabalin Pfizer?
English: The company that makes Lyrica has agreed that its scientific data can be used for Pregabalin Pfizer (‘informed consent').
Slovenian: Družba, ki proizvaja zdravilo Lyrica, se strinja, da se lahko znanstveni podatki o tem zdravilu uporabijo tudi za zdravilo Pregabalin Pfizer („uporaba dokumentacije s soglasjem“).
English: A risk management plan has been developed to ensure that Pregabalin Pfizer is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Pregabalin Pfizer je bil pripravljen načrt obvladovanja tveganj.
English: Pregabalin Pfizer is a medicine that contains the active substance pregabalin.
Slovenian: Pregabalin Pfizer je zdravilo, ki vsebuje zdravilno učinkovino pregabalin.
English: In neuropathic pain, the benefits of Pregabalin Pfizer were evaluated for up to 12 weeks using a standard pain questionnaire.
Slovenian: Kar zadeva nevropatske bolečine, so koristi zdravila Pregabalin Pfizer v obdobju do 12 tednov ocenjevali s standardnim vprašalnikom za točkovanje bolečine.
English: The most common side effects with Pregabalin Pfizer (seen in more than 1 patient in 10) are dizziness and somnolence (sleepiness).
Slovenian: Najpogostejša neželena učinka zdravila Pregabalin Pfizer (opažena pri več kot 1 bolniku od 10) sta omotica in zaspanost.
English: • neuropathic pain (pain due to nerve damage), including peripheral neuropathic pain, such as the pain experienced by patients with diabetes or herpes zoster (shingles), and central neuropathic pain, such as the pain experienced by patients who have had a spinal cord injury;
Slovenian: • nevropatsko bolečino (bolečino zaradi poškodbe živcev), vključno s periferno nevropatsko bolečino, kot se pojavlja pri bolnikih s sladkorno boleznijo ali pasovcem, in centralno nevropatsko bolečino, kot se pojavlja pri bolnikih s poškodbo hrbtenjače;
English: For more information about treatment with Pregabalin Pfizer, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Pregabalin Pfizer preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: After three to seven days, the dose can be increased to 300 mg per day.
Slovenian: Po treh do sedmih dneh se odmerek lahko poveča na 300 mg na dan. Odmerki se lahko povečajo največ dvakrat, dokler ni dosežen najučinkovitejši odmerek.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Pregabalin Pfizer, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Pregabalin Pfizer in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: The CHMP decided that Pregabalin Pfizer's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Pregabalin Pfizer večje od z njim povezanih tveganj, in priporočil, da se zanj izda dovoljenje za promet.
English: For practical information about using Pregabalin Pfizer, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Pregabalin Pfizer naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: About 45% of the patients taking 600 mg Pregabalin Pfizer a day and about 35% of those taking 300 mg Pregabalin Pfizer a day had a reduction in seizures of 50% or more.
Slovenian: Pri približno 45 % bolnikov, ki so jemali 600 mg zdravila Pregabalin Pfizer na dan, in pri približno 35 % bolnikov, ki so jemali 300 mg zdravila Pregabalin Pfizer na dan, se je število napadov zmanjšalo za 50 % ali več.
English: What is Pregabalin Pfizer and what is it used for?
Slovenian: Kaj je zdravilo Pregabalin Pfizer in za kaj se uporablja?
English: What are the risks associated with Pregabalin Pfizer?
Slovenian: Kakšna tveganja so povezana z zdravilom Pregabalin Pfizer?
English: Pregabalin Pfizer has been compared with placebo (a dummy treatment) in 22 studies.
Slovenian: Zdravilo Pregabalin Pfizer so v 22 študijah primerjali s placebom (zdravilom brez zdravilne učinkovine).
English: Stopping treatment with Pregabalin Pfizer should also be done gradually, over at least a week.
Slovenian: Največji odmerek je 600 mg na dan. Tudi prenehanje zdravljenja z zdravilom Pregabalin Pfizer mora potekati postopno, in sicer najmanj en teden.
English: In epilepsy, the benefits of Pregabalin Pfizer were evaluated in 3 studies involving 1,000 patients that looked at how much it reduced the number of seizures patients had after 11 to 12 weeks.
Slovenian: Pri epilepsiji so koristi zdravila Pregabalin Pfizer ocenjevali v treh študijah, v katerih je sodelovalo 1 000 bolnikov in v katerih so preučevali, v kolikšni meri se je ob jemanju zdravila zmanjšalo število napadov.
English: The recommended starting dose of Pregabalin Pfizer is 150 mg per day,
Slovenian: Priporočeni začetni odmerek zdravila Pregabalin Pfizer je 150 mg na dan, ki se porazdeli na dva ali tri odmerke.
English: What benefits of Pregabalin Pfizer have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Pregabalin Pfizer izkazalo v študijah?
English: Other information about Pregabalin Pfizer
Slovenian: Druge informacije o zdravilu Pregabalin Pfizer
English: Pregabalin Pfizer was more effective than placebo in generalised anxiety disorder: in 8 studies involving over 3,000 patients, 52% of the patients taking Pregabalin Pfizer had an improvement of 50% or more in their anxiety measured with a standard anxiety questionnaire, compared with 38% of the patients taking placebo.
Slovenian: Zdravilo Pregabalin Pfizer je bilo pri generaliziranih anksioznih motnjah učinkovitejše od placeba: v osmih študijah, v katerih je sodelovalo več kot 3 000 bolnikov, je bilo pri 52 % bolnikov, ki so jemali zdravilo Pregabalin Pfizer, izboljšanje 50 % ali več v primerjavi z 38 % bolnikov, ki so jemali placebo.
English: In a smaller study involving 137 patients with central neuropathic pain due to a spinal cord injury, 22% of patients treated with Pregabalin Pfizer had a decrease in pain scores of 50% or more, compared with 8% of the patients treated with placebo.
Slovenian: V manjši študiji, v katerih je sodelovalo 137 bolnikov s centralno nevropatsko bolečino, ki je bila posledica poškodbe hrbtenjače, je bilo pri 22 % bolnikov, zdravljenih z zdravilom Pregabalin Pfizer, doseženo izboljšanje točkovanja bolečine za 50 % ali več v primerjavi z 8 % bolnikov, ki so se zdravili s placebom.
English: In 10 studies involving over 3,000 patients with peripheral neuropathic pain (either diabetic pain or shingles), 35% of the patients treated with Pregabalin Pfizer had a decrease in pain scores of 50% or more, compared with 18% of the patients treated with placebo.
Slovenian: V desetih študijah, v katerih je sodelovalo 3 000 bolnikov s periferno nevropatsko bolečino (bolečo diabetično nevropatijo ali pasovcem), je bilo pri 35 % bolnikov, zdravljenih z zdravilom Pregabalin Pfizer, doseženo izboljšanje točkovanja bolečine za 50 % ali več v primerjavi z 18 % bolnikov, ki so se zdravili s placebom.
English: Why is Pregabalin Pfizer approved?
Slovenian: Zakaj je bilo zdravilo Pregabalin Pfizer odobreno?
English: It is not intended to provide practical advice on how to use Pregabalin Pfizer.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: How is Pregabalin Pfizer used?
Slovenian: Kako se zdravilo Pregabalin Pfizer uporablja?
English: How does Pregabalin Pfizer work?
Slovenian: Kako zdravilo Pregabalin Pfizer deluje?
English: Contact our press officers Monika Benstetter or Martin Harvey
Slovenian: Stopite v stik z našima predstavnikoma za tisk Monika Benstetter ali Martin Harvey
English: Information for women
Slovenian: Informacije za ženske
English: • Women who have any questions or concerns should speak to their doctor or pharmacist.
Slovenian: • Ženske, ki imajo kakršna koli vprašanja ali pomisleke, naj se posvetujejo z zdravnikom ali farmacevtom.
English: Information to healthcare professionals
Slovenian: Informacije za zdravstveno osebje
English: • a meta-analysis of three WHO studies3,4,5, which primarily included African and Asian women.
Slovenian: • metaanalizo treh študij SZO3,4,5, ki so v glavnem zajele Afričanke in Azijke.
English: For more information on these studies, see the CHMP assessment report for ellaOne: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR__Public_assessment_report/human/001027/WC500023673.pdf
Slovenian: Za več informacij o teh študijah glejte poročilo o oceni CHMP za zdravilo ellaOne: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR__Public_assessment_report/human/001027/WC500023673.pdf
English: Tel. +44 (0)20 3660 8427 E-mail: press@ema.europa.eu
Slovenian: Tel.: +44 (0)20 3660 8427 E-pošta: press@ema.europa.eu
English: Studies HRA2914-507, HRA2914-508, HRA2914-509 and HRA2914-513.
Slovenian: Študije HRA2914-507, HRA2914-508, HRA2914-509 in HRA2914-513.
English: The review was conducted by the Committee for Medicinal Products for Human Use (CHMP), the Committee responsible for questions concerning medicines for human use, which adopted the Agency's final opinion.
Slovenian: Pregled je izvedel Odbor za zdravila za uporabo v humani medicini (CHMP), pristojni odbor za vprašanja glede zdravil za uporabo v humani medicini, ki je sprejel končno mnenje agencije.
English: The review of emergency contraceptives containing levonorgestrel and ulipristal acetate was initiated in January 2014 at the request of Sweden, under Article 31 of Directive 2001/83/EC.
Slovenian: Pregled urgentnih kontraceptivov, ki vsebujejo levonorgestrel in ulipristalacetat, se je pričel januarja 2014 na zahtevo Švedske v skladu s členom 31 Direktive 2001/83/ES.
English: The CHMP opinion was then forwarded to the European Commission, which issued a final legally binding decision on 30 September 2014.
Slovenian: Mnenje CHMP je bilo nato poslano Evropski komisiji, ki je 30. septembra 2014 izdala končno pravno zavezujočo odločitev.
English: Emergency contraceptives work by stopping or delaying ovulation.
Slovenian: Urgentni kontraceptivi delujejo tako, da zaustavijo ali odložijo ovulacijo.
English: The CHMP recommendation was sent to the European Commission, which issued a legally binding decision valid throughout the EU on 30 September 2014.
Slovenian: Priporočilo CHMP je bilo poslano Evropski komisiji, ki je 30. septembra 2014 izdala pravno zavezujoč sklep, veljaven po celotni EU.
English: The emergency contraceptives included in this review are medicines containing levonorgestrel, such as Norlevo, Levonelle/Postinor and Levodonna, which have been authorised in the EU through national procedures.
Slovenian: Urgentni kontraceptivi, vključeni v ta pregled, so zdravila, ki vključujejo levonorgestrel, kot so Norlevo, Levonelle/Postinor in Levodonna, ki so pridobila dovoljenje za promet v EU na podlagi nacionalnih postopkov.
English: Both meta-analyses did not include off-label use (i.e. intake later than 72 hours after unprotected sexual intercourse).
Slovenian: Iz obeh metaanaliz je bila izključena nenamenska uporaba (tj. uporaba več kot 72 ur po nezaščitenem spolnem odnosu).
English: However, in order to maximise the likelihood that they will work, it is important that they are taken as soon as possible after unprotected intercourse.
Slovenian: Vendar pa jih je, da bi kar najbolj povečali verjetnost, da bodo delovali, treba vzeti čim prej po nezaščitenem spolnem odnosu.
English: Similarly, for ulipristal acetate, although limited data from clinical trials suggest a possible trend for a reduced contraceptive effect, the data are too limited and insufficiently precise to draw definite conclusions.
Slovenian: Podobno so pri ulipristalacetatu, čeprav omejeni podatki iz kliničnih preskušanj kažejo na možen trend zmanjševanja kontracepcijskega učinka, podatki preveč omejeni in premalo natančni, da bi omogočali dokončne zaključke.
English: For ulipristal acetate, the Agency considered the following data:
Slovenian: Pri ulipristalacetatu je agencija upoštevala naslednje podatke:
English: The review also included a centrally-authorised medicine, ellaOne, which contains ulipristal acetate and was granted a marketing authorisation in the EU in 2009.
Slovenian: Pregled je prav tako vključeval zdravilo ellaOne, odobreno po centraliziranem postopku, ki vsebuje ulipristalacetat in je pridobilo dovoljenje za promet v EU leta 2009.
English: EllaOne can only be obtained with a prescription.
Slovenian: Izdaja zdravila EllaOne je le na recept.
English: For emergency contraceptives containing levonorgestrel, the Agency considered the following data:
Slovenian: Pri urgentnih kontraceptivih, ki vsebujejo levonorgestrel, je agencija upoštevala naslednje podatke:
English: • An EU-wide review was carried out to assess whether emergency contraceptives are less effective in overweight or obese women.
Slovenian: • Izveden je bil pregled po celotni EU, da bi ocenili, ali so urgentni kontraceptivi manj učinkoviti pri ženskah s čezmerno telesno maso ali debelih ženskah.
English: Women should be reminded that emergency contraceptives should be taken as soon as possible following unprotected sexual intercourse.
Slovenian: Ženske bi morale biti opozorjene, da morajo urgentni kontraceptiv vzeti čim prej po nezaščitenem spolnem odnosu.
English: On 24 July 2014, the European Medicines Agency concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate to assess whether increased bodyweight affects the effectiveness of these medicines in preventing unintended pregnancy following unprotected sexual intercourse or contraceptive failure.
Slovenian: 24. julija 2014 je Evropska agencija za zdravila zaključila svoj pregled urgentnih kontraceptivov, ki vsebujejo levonorgestrel ali ulipristalacetat, v okviru katerega je ugotavljala, ali višja telesna masa vpliva na učinkovitost teh zdravil pri preprečevanju neželene nosečnosti po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji.
English: • Healthcare professionals should continue to remind women that emergency contraception is an occasional ‘rescue' method and should not replace a regular contraceptive method.
Slovenian: • Zdravstveni delavci bi morali še naprej opozarjati ženske, da so urgentni kontraceptivi občasna metoda „v sili“ in da ne smejo nadomestiti redne kontracepcijske metode.
English: Those containing levonorgestrel can be used up to 72 hours after unprotected sexual intercourse or contraceptive failure, while ulipristal acetate can be used up to 120 hours.
Slovenian: Kontraceptivi, ki vsebujejo levonorgestrel, se lahko uporabijo do 72 ur po nezaščitenem spolnem odnosu ali neučinkoviti kontracepciji, medtem ko se lahko ulipristalacetat uporabi do 120 ur kasneje.